2024
Performance of contemporary cardiovascular risk stratification scores in Brazil: an evaluation in the ELSA-Brasil study
Camargos A, Barreto S, Brant L, Ribeiro A, Dhingra L, Aminorroaya A, Bittencourt M, Figueiredo R, Khera R. Performance of contemporary cardiovascular risk stratification scores in Brazil: an evaluation in the ELSA-Brasil study. Open Heart 2024, 11: e002762. PMID: 38862252, PMCID: PMC11168182, DOI: 10.1136/openhrt-2024-002762.Peer-Reviewed Original ResearchConceptsPooled Cohort EquationsELSA-BrasilRisk scoreCardiovascular diseaseCVD eventsCommunity-based cohort studyArea under the receiver operating characteristic curveCVD risk scoreELSA-Brasil studyIncident CVD eventsMiddle-income countriesAdjudicated CVD eventsCardiovascular disease riskCVD scoreCohort EquationsNational guidelinesRisk stratification scoresWhite womenAge/sex groupsCohort studyProspective cohortLMICsSex/race groupsHigher incomeRisk discrimination
2022
Epidemiology, burden, and attributable risks of infective endocarditis in Iran and its provinces: From 1990 to 2019
Ajam A, Shobeiri P, Keykhaei M, Moghaddam S, Momtazmanesh S, Masinaei M, Esfahani Z, Rezaei N, Naderian M, Aminorroaya A, Rashidi M, Rezaei N, Larijani B, Malakan Rad E, Farzadfar F. Epidemiology, burden, and attributable risks of infective endocarditis in Iran and its provinces: From 1990 to 2019. International Journal Of Cardiology 2022, 363: 202-209. PMID: 35777487, DOI: 10.1016/j.ijcard.2022.06.060.Peer-Reviewed Original ResearchConceptsAge-standardized mortality ratesAge-standardized incidence rateAge-standardized prevalence rateDisability-adjusted life yearsAge-standardized DALY rateMortality rateInfectious disease associated with significant morbidityDALY ratesRisk of infective endocarditisDisease associated with significant morbidityGlobal burdenIncidence rateLife yearsPrevalence ratesEscalating incidenceAge groupsStudy dataInfective endocarditisEpidemiological indicesBurdenSignificant morbidityGBDEndocarditisMortalityProvincial levelRheumatic Heart Disease Is a Neglected Disease Relative to Its Burden Worldwide: Findings From Global Burden of Disease 2019
Ghamari S, Abbasi‐Kangevari M, Moghaddam S, Aminorroaya A, Rezaei N, Shobeiri P, Esfahani Z, Malekpour M, Rezaei N, Ghanbari A, Keykhaei M, Naderian M, Larijani B, Majnoon M, Farzadfar F, Mokdad A. Rheumatic Heart Disease Is a Neglected Disease Relative to Its Burden Worldwide: Findings From Global Burden of Disease 2019. Journal Of The American Heart Association 2022, 11: e025284. PMID: 35730651, PMCID: PMC9333364, DOI: 10.1161/jaha.122.025284.Peer-Reviewed Original ResearchConceptsDisability-adjusted life yearsRheumatic heart diseaseAge-standardized incidenceAge-standardized deathBirth cohort effectsSociodemographic indexRheumatic heart disease burdenLife yearsPrevalence ratesCohort effectsHighest age-standardized incidenceAge-standardized disability-adjusted life yearsAge-period-cohort analysisDisability-adjusted life year ratesGlobal Burden of DiseasePrevalence rate of rheumatic heart diseaseHeart diseaseMiddle-income countriesSociodemographic index levelsBurden of diseaseBurden of rheumatic heart diseaseRate of rheumatic heart diseaseIncidence of rheumatic heart diseaseCountry's sociodemographic indexAssess inequalitiesGlobal and regional burden and quality of care of non-rheumatic valvular heart diseases: a systematic analysis of Global Burden of Disease 1990–2017
Nejad M, Ahmadi N, Mohammadi E, Shabani M, Sherafati A, Aryannejad A, Rezaei N, Ghanbari A, Yoosefi M, Aminorroaya A, Shabani M, Rezaei N, Salavati T, Larijani B, Naderimagham S, Farzadfar F. Global and regional burden and quality of care of non-rheumatic valvular heart diseases: a systematic analysis of Global Burden of Disease 1990–2017. International Journal For Quality In Health Care 2022, 34: mzac026. PMID: 35434737, DOI: 10.1093/intqhc/mzac026.Peer-Reviewed Original ResearchConceptsQuality of care indexGlobal Burden of DiseaseNon-rheumatic valvular heart diseaseQuality of careSociodemographic indexBurden of diseaseQuality of care index scoreLow SDI quintileWHO world regionsSociodemographic index countriesHeart diseaseHealthcare qualityHealthcare accessCare indexEastern Mediterranean RegionHealthcare systemRegional burdenGlobal burdenWestern Pacific RegionValvular heart diseaseHealthcareAge groupsQuintilePrimary measureCareCompression stockings for treating vasovagal syncope (COMFORTS-II) trial: Rationale and design of a triple-blind, multi-center, randomized controlled trial
Tavolinejad H, Poopak A, Sadeghian S, Bozorgi A, Oraii A, Mollazadeh R, Emkanjoo Z, Kiarsi M, Shahabi J, Jalali A, Alaeddini F, Ariannejad H, Yadangi S, Oraii S, Kheirkhah J, Assadianrad M, Aminorroaya A, Tajdini M. Compression stockings for treating vasovagal syncope (COMFORTS-II) trial: Rationale and design of a triple-blind, multi-center, randomized controlled trial. American Heart Journal 2022, 249: 57-65. PMID: 35405100, DOI: 10.1016/j.ahj.2022.04.002.Peer-Reviewed Original ResearchConceptsElastic compression stockingsRandomized controlled trialsVasovagal syncopeProportion of participantsCompression stockingsTriple-blindLifestyle modification recommendationsVenous returnCo-primary outcomesPatient-reported adverse effectsTreat vasovagal syncopeVasovagal syncope recurrencesDiary sheetsSecondary outcomesStudy armsReduced venous returnSyncope recurrenceTrial backgroundSyncopal episodesFollow-upClinical trialsParticipantsMulti-centerOnline randomizationRecurrence
2021
How the scientific community responded to the COVID-19 pandemic: A subject-level time-trend bibliometric analysis
Malekpour M, Abbasi-Kangevari M, Azadnajafabad S, Ghamari S, Rezaei N, Rezazadeh-Khadem S, Rezaei N, Aminorroaya A, Abdolhamidi E, Fateh S, Haghshenas R, Roshani S, Ahmadi N, Jamshidi K, Naderimagham S, Farzadfar F. How the scientific community responded to the COVID-19 pandemic: A subject-level time-trend bibliometric analysis. PLOS ONE 2021, 16: e0258064. PMID: 34591941, PMCID: PMC8483337, DOI: 10.1371/journal.pone.0258064.Peer-Reviewed Original ResearchConceptsPublication countsBibliographic recordsBibliometric analysisScience domainBibliographic dataCOVID-19 literatureInternational collaborationResearch publicationsVital fundsMedical publicationsPhysical sciencesOngoing situationAnalysis backgroundSocial sciencesScientific community's interestCollaborationLife sciencesScienceRedundancyDomainMedical subjectsClassificationScientific communityInternational publicationsCommunity interests
2020
Opium and cardiovascular health: A devil or an angel?
Roayaei P, Aminorroaya A, Vasheghani-Farahani A, Oraii A, Sadeghian S, Poorhosseini H, Masoudkabir F. Opium and cardiovascular health: A devil or an angel? Indian Heart Journal 2020, 72: 482-490. PMID: 33357635, PMCID: PMC7772609, DOI: 10.1016/j.ihj.2020.10.003.Peer-Reviewed Original ResearchConceptsOpium consumptionCardiovascular diseaseEffects of opium consumptionMedical staffChronic diseasesIllicit drug consumptionStable coronary artery diseaseHigher consumptionConsumption of opiumRisk factorsAcute coronary syndromeCoronary artery diseaseAbused substancesTraditional beliefsDiabetes mellitusCoronary syndromeDrug consumptionDiabetic patientsArtery diseaseHealthy individualsAmeliorative effectDiseaseStaffTobacco